Sp1291a
GI PCR PANELS: HOW TO UTILIZE MOLECULAR SYNDROMIC TESTING IN YOUR PRACTICE
Date
May 9, 2023
Society: DDW
Join us as we dive deep into rapid multi-pathogen diagnostic testing. We'll discuss use cases, how to interpret syndromic testing data, and how this data can positively impact clinical decision making. Learn how syndromic testing can do more, faster. Sponsored by bioMérieux
Join us as we dive deep into rapid multi-pathogen diagnostic testing. We'll discuss use cases, how to interpret syndromic testing data, and how this data can positively impact clinical decision making. Learn how syndromic testing can do more, faster. Sponsored by bioMérieux
Presenter
NYU Langone Health
Tracks
Related Products
TOFACITINIB UPTAKE BY PATIENT-DERIVED INTESTINAL ORGANOIDS PREDICTS INDIVIDUAL CLINICAL RESPONSIVENESS
BACKGROUND: Despite increasing therapeutic options in the treatment of ulcerative colitis (UC), achieving disease remission remains a major clinical challenge. Nonresponse to therapy is common and clinicians have little guidance in selecting the optimal therapy for an individual patient…
COST-EFFECTIVENESS OF A BIOMARKER MONITORING STRATEGY COMPARED TO ENDOSCOPIC MONITORING IN LOW-RISK POSTOPERATIVE CROHN’S DISEASE.
INTRODUCTION: Recent guidelines propose a fecal calprotectin (FCP) monitoring strategy in the year after Crohn’s disease (CD) resection for low-risk individuals or those receiving pharmacologic prophylaxis to prevent postoperative recurrence (POR)…
CLINICAL AND PSYCHOSOCIAL RESPONSE ARE ASSOCIATED WITH IMPROVED SEXUAL DYSFUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGIC THERAPY
Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
